Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Abdominal Aortic Aneurysm (AAA) Repair Devices Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.
Global Expansion of Abdominal Aortic Aneurysm Repair Devices Accelerated by Technological Innovations and Heightened Prevalence of Risk Factors
The latest market research report indicates a substantial uptick in the global market for abdominal aortic aneurysm (AAA) repair devices, driven by a combination of advancing age demographics, enhanced interventional techniques, and a higher incidence of risk factors such as smoking. A detailed analysis forecasts the market to burgeon from $2.52 billion in 2024 to an impressive $3.22 billion by 2028, representing a sustained compound annual growth rate (CAGR) of 6.3%.
Shine a spotlight on the Asia-Pacific region, which is slated to experience the fastest growth within this sector during the forecast period. This region's growth trajectory is bolstered by increasing healthcare infrastructure investment, which substantially improves access to sophisticated medical interventions.
Key Trends Fueling the Market Demand
Technological Breakthroughs Revolutionize Treatment Outcomes
The increasing demand for minimally invasive procedures marks a pronounced trend within the AAA repair devices market. Cutting-edge devices, such as the Excluder Conformable AAA Endoprosthesis, redefine the standards of care by delivering superior anatomical fit and reduced procedural risks.
Prevalence of Smoking Escalates Risk, Demand for Repair Devices
The abdomen's resilience against AAA is compromised with the rise of smoking prevalence, spotlighting the critical role of stent grafts in preemptive care and improving patients' life expectancy. These devices are instrumental in strengthening weakened aortic sections, consequently serving an ever-growing patient demographic.
Major Market Developments
Notable acquisitions such as Endologix LLC's strategic acquisition of PQ Bypass, Inc. mark significant industry developments, with companies broadening their portfolios to include innovative stenting solutions. This is indicative of the concerted efforts by market players to consolidate their presence and enhance their technological prowess within the AAA repair devices field.
Comprehensive Analysis Delivers Market Insights
The report articulates a comprehensive exploration of market segments, including the increasing adoption of endovascular stent graft systems and their crucial role in treating infrarenal and pararenal AAA sites. The wide array of end-users, like hospitals and ambulatory surgical centers, underline the market's expansive consumer base.
- Evaluation of the underlying factors propelling growth, such as demographic trends and lifestyle risks
- Insight into the competitive landscape, emphasizing recent innovations and strategic industry activities
- Projection of market dynamics in North America, identified as the preeminent region in this market sphere
- Delineation of market value in terms of revenue generated by geographical consumption
The synthesis provided in this market research report is an essential tool for stakeholders, investors, and participants looking to comprehend the market's current state and forecasted progression. By offering a granular viewpoint of market structure and potential, this report is instrumental for informed decision-making and long-term strategic planning.
For additional insights and an in-depth understanding of this thriving market, professionals and analysts in the healthcare and medical devices industries will find this report to be an invaluable resource as they navigate the ever-evolving landscape of abdominal aortic aneurysm repair devices.
Key Markets Covered:
- By Product Type: Endovascular Stent Graft System; Synthetic Graft System
- By Site: Infrarenal AAA; Pararenal AAA
- By Application: Traditional Anatomy; Complex Anatomy
- By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Companies Profiled:
- Cardiatis S.A
- Cardinal Health Inc.
- Cook Medical LLC
- Endologix Inc.
- Lombard Medical Inc.
- Medtronic plc
- Terumo Corporation
- W.L. Gore and Associates Inc.
- C. R. Bard
- Jotec GmbH
- Gore Medical
- Abbott Laboratories
- LivaNova plc
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- MicroPort Scientific Corporation LLC
- Lifetech Scientific (Shenzhen) Co. Ltd.
- Hangzhou Endonom Medtech Co. Ltd.
- Latecba SA
- Nectero Medical
- Beijing Jinyu Medical Device Co. Ltd.
- Beijing Endoncare Medical Devices Co. Ltd.
- Shanghai MicroPort Endovascular Medical Devices Co. Ltd.
- Lepu Medical Technology Co. Ltd.
- Beijing Advanced Cardiovascular Technologies Co. Ltd.
- CryoLife Inc.
- Baxter International Inc.
- Edwards Lifesciences Corporation
- B. Braun Melsungen AG
- Getinge AB
For more information about this report visit https://www.researchandmarkets.com/r/rnf0ty
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
